Phase 2 Study of the Safety of Diannexin in Kidney Transplant Recipients
Clinical trial NCT00615966 · COMPLETED
Trial details
- NCT number
- NCT00615966
- Sponsor
- Alavita Pharmaceuticals Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-02-01
- Primary completion
- 2009-01-01
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.